The vascular endothelium starts to age at the first heartbeat. There is no longer a need to
demonstrate that an increased resting heart rate—above 70 bpm—is associated with the …

Arterial stiffness plays a key role in the pathophysiology of the cardiovascular system. Some
indices of arterial stiffness (pulse wave velocity, augmentation index, characteristics of …

The urgent need for a cure for early phase COVID-19 infected patients critically underlines
drug repositioning strategies able to efficiently identify new and reliable treatments by …

One‐third of cancer patients undergoing chemotherapy treatment often display symptoms of
depression leading to poor adherence and decreased quality of life. Thus, this study aimed …

Nebivolol (NBV), a BCS class II anti-hypertensive drug, suffers from limited solubility and
oral bioavailability. Nanosized ethosomes were adopted as an approach to solubilize and …

Materials and Methods: In this single arm, open-labeled study, 13 patients were given
nebivolol, 5 mg orally once daily for 15 days. Primary outcome was change in central aortic …

What is known and objective Nebivolol is a highly selective beta‐blocker with additional
vasodilator properties, widely used in the clinical practice for the treatment of hypertension …

The morning blood pressure surge (MBPS) has been shown to be an independent predictor
of cardiovascular events. There is insufficient evidence on the effect of nebivolol, a …

Introduction Cardiovascular diseases are the main cause of mortality worldwide, and
systemic arterial hypertension is associated with a large number of these cases. The …

The pharmacological control of arterial hypertension is a very frequent issue in clinical
practice and some critical aspects can arise in particular circumstances and with particular …